Ekonomia Online
LATEST

Letter to Minister Arben Vitia from cancer patient who died: I urge you to take measures to ensure the therapy!

Letter to Minister Arben Vitia from cancer patient who died: I urge you to take measures to ensure the therapy!

A patient from the Prizren region, who was being treated at the Oncology Clinic, died in October of this year. She was suffering from breast cancer.

Immediately after her death, the “Renesansa” organization reacted on social media, claiming that she died due to a shortage of the drug “Palbociclib”.

As Violeta Pirana claimed, she had raised the shortage of the drug with which the patient from the Prizren region was being treated with the Minister of Health, Arben Vitia, and the University Clinical Center of Kosovo (UCCK) during June.

“This was the case with the woman who died. I stand by that (the statement that the patient died due to a shortage of the drug), because two months later…, I sent letters to the minister, the UCCK and the director of Oncology saying that the drug (Palbociclib) was unavailable” – said Violeta Pirana of “Renesansa”.

The patient herself, who died in October and had been treated with the drug “Palbociclib”, had sent a letter by email to Minister Arben Vitia, the Ministry of Health at its official email address, UCCK Director Mentor Zejnullahu, and Oncology Clinic Director Ilir Kurtishi.

She had sent the letter to each of them separately on 28.06.2026.

In the letter, obtained by KALLXO and addressed by the patient to Minister Arben Vitia, she asked that measures be taken to ensure the therapy.

“I have used this therapy for 6 months and it has yielded very good results. My pain has eased, my health has improved, and my hope of continuing to live—which I cherish very much—and being with my family has returned…” – the patient wrote in the letter dated 28.06.2026.

She went on to mention the shortage of the “Palbociclib” therapy.

“But my bad luck is that since May 10, when I was supposed to take the therapy, I have not used it because it is unavailable, even though it is my hope for life… The pain immediately returned, just as it was before I started using the therapy. This shortage is having a very serious impact on my daily life” – said the patient who died in October of this year.

“Respectfully, I ask you to take the necessary measures as soon as possible to ensure the ‘Palbociclib’ therapy, as this therapy is vital for me and many other patients” – the letter said.

On 10.11.2026, KALLXO.com sent questions to the Minister of Health, Arben Vitia, the Ministry of Health at its official email address, UCCK Director Mentor Zejnullahu, and Oncology Director Ilir Kurtishi, to confirm whether the patient’s request had been addressed.

However, they had not responded by the time this article was published.

Related